Agilent Q3 Revenues up 2 Percent; Lowers FY 2012 Estimates | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent Technologies reported after the close of the market on Wednesday that revenues during its fiscal third quarter inched up 2 percent year over year as the company missed the average analyst estimate on the top and bottom line.

For the three months ended July 31, revenues totaled $1.72 billion, compared to $1.69 billion for the third quarter a year ago. The company fell short of the average analyst estimate of $1.79 billion.

Orders during the quarter were down 2 percent to $1.66 billion from $1.69 billion a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.